Sponsor Pipeline

TScan Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
4
Recruiting
1
Phase 3
10
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-23 NCT07702578
A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic…		 Trial sites expanded: 17 -> 26 locations
Active Trials by Phase
Phase 3
1
Phase 1
2
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07702578 A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic… AML Recruiting
Phase 1
NCT05473910 A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing… AML Recruiting
NCT05973487 A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally… Head and Neck Cancer Active, Not Recruiting
Not specified
NCT06976736 A Long Term Follow-up Study of TScan TCR-T Products AML Recruiting
NCT06587828 A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in… Autoimmune Diseases Recruiting
NCT05812027 A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in… Head and Neck Cancer Active, Not Recruiting
Disease Areas
Acute Myeloid Leukemia (AML) (3) Myelodysplastic Syndromes (MDS) (3) Cervical Cancer (2) Melanoma (2) Head & Neck Cancer (2) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Sarcoma (1) Ovarian Cancer (1) Multiple Sclerosis (1)
Get alerts when TScan Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free